Vose J - Search Results

1

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project. Vose J, et al. J Clin Oncol. 2008 Sep 1;26(25):4124-30. doi: 10.1200/JCO.2008.16.4558. Epub 2008 Jul 14. J Clin Oncol. 2008. PMID: 18626005

2

Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.

Letheby B, Jackson J, Greally J, Warkentin P, Smith D, Vose J, Bierman P, Kessinger A, Coccia P, Armitage J. Letheby B, et al. Among authors: vose j. Prog Clin Biol Res. 1992;377:345-51. Prog Clin Biol Res. 1992. PMID: 1279712 No abstract available.

3

Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.

Vose JM, Bierman PJ, Anderson JR, Kessinger A, Pierson J, Nelson J, Frappier B, Schmit-Pokorny K, Weisenburger DD, Armitage JO. Vose JM, et al. Blood. 1992 Oct 15;80(8):2142-8. Blood. 1992. PMID: 1356515 Free article.

4

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.

Gordon BG, Warkentin PI, Weisenburger DD, Vose JM, Sanger WG, Strandjord SE, Anderson JR, Verdirame JD, Bierman PJ, Armitage JO, et al. Gordon BG, et al. Among authors: vose jm. Blood. 1992 Dec 1;80(11):2938-42. Blood. 1992. PMID: 1450419 Free article.

5

Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease.

Sisson JH, Thompson AB, Anderson JR, Robbins RA, Spurzem JR, Spence PR, Reed EC, Armitage JO, Vose JM, Arneson MA, et al. Sisson JH, et al. Among authors: vose jm. Am Rev Respir Dis. 1992 Aug;146(2):439-43. doi: 10.1164/ajrccm/146.2.439. Am Rev Respir Dis. 1992. PMID: 1489136

6

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.

Kessinger A, Bierman PJ, Vose JM, Armitage JO. Kessinger A, et al. Among authors: vose jm. Blood. 1991 Jun 1;77(11):2322-5. Blood. 1991. PMID: 1674890 Free article.

7

The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.

Vose JM, Bierman PJ, Kessinger A, Coccia PF, Anderson J, Oldham FB, Epstein C, Armitage JO. Vose JM, et al. Bone Marrow Transplant. 1991 Feb;7(2):139-43. Bone Marrow Transplant. 1991. PMID: 1675592

8

High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.

Kessinger A, Vose JM, Bierman PJ, Armitage JO. Kessinger A, et al. Among authors: vose jm. Exp Hematol. 1991 Nov;19(10):1013-6. Exp Hematol. 1991. PMID: 1680733

9

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.

Coiffier B, Gisselbrecht C, Vose JM, Tilly H, Herbrecht R, Bosly A, Armitage JO. Coiffier B, et al. Among authors: vose jm. J Clin Oncol. 1991 Feb;9(2):211-9. doi: 10.1200/JCO.1991.9.2.211. J Clin Oncol. 1991. PMID: 1703226

10

Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.

Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Bashir RM, et al. Among authors: vose jm. Am J Clin Oncol. 1991 Dec;14(6):478-82. doi: 10.1097/00000421-199112000-00004. Am J Clin Oncol. 1991. PMID: 1720278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

584 results

Search Page

Filters